Search research articles
Contact Us
Filters
Showing results (21-30 of 111) with videos related to
Page
of 12
Sort By:
Radiation Oncology (London, England)
|
May 9, 2025
Preoperative chemoradiotherapy for esophageal or gastroesophageal junction cancer: results from a retrospective study using extended CROSS regimen
Tobias Haltmeier, Jennifer Brazerol, Yves Borbely, et al.
Journal of Cancer Research and Clinical Oncology
|
March 26, 2023
Heat shock protein 90 (HSP90) inhibitors in gastrointestinal cancer: where do we currently stand?-A systematic review
Christian Tibor Josef Magyar, Yogesh K Vashist, Deborah Stroka, et al.
Pathology, Research and Practice
|
May 29, 2021
RHAMM in liver metastases of stage IV colorectal cancer with mismatch-repair proficient status correlates with tumor budding, cytotoxic T-cells and PD-1/PD-L1
Sandra Burren, Katharina Reche, Annika Blank, et al.
International Journal of Molecular Sciences
|
July 27, 2024
Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (<i>DPYD</i>)
Alisa Ambrodji, Angélique Sadlon, Ursula Amstutz, et al.
Hematological Oncology
|
February 18, 2015
Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma
Martin D Berger, Giacomo Branger, Bernd Klaeser, et al.
Histopathology
|
January 7, 2017
Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer
Gregor Rieger, Viktor H Koelzer, Heather E Dawson, et al.
Haematologica
|
June 20, 2020
Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis
Martin D Berger, Sven Trelle, Annina E Büchi, et al.
Journal of Personalized Medicine
|
August 27, 2021
LAG-3 Expression Predicts Outcome in Stage II Colon Cancer
Gaëlle Rhyner Agocs, Naziheh Assarzadegan, Richard Kirsch, et al.
Human Pathology
|
November 15, 2018
Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer
Heather Dawson, Francesca Galuppini, Peter Träger, et al.
Cancer Treatment Reviews
|
December 6, 2017
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga, Wu Zhang, Madiha Naseem, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 111) with videos related to
Sort By:
Page
of 12
Radiation Oncology (London, England)
|
May 9, 2025
Preoperative chemoradiotherapy for esophageal or gastroesophageal junction cancer: results from a retrospective study using extended CROSS regimen
Tobias Haltmeier, Jennifer Brazerol, Yves Borbely, et al.
Journal of Cancer Research and Clinical Oncology
|
March 26, 2023
Heat shock protein 90 (HSP90) inhibitors in gastrointestinal cancer: where do we currently stand?-A systematic review
Christian Tibor Josef Magyar, Yogesh K Vashist, Deborah Stroka, et al.
Pathology, Research and Practice
|
May 29, 2021
RHAMM in liver metastases of stage IV colorectal cancer with mismatch-repair proficient status correlates with tumor budding, cytotoxic T-cells and PD-1/PD-L1
Sandra Burren, Katharina Reche, Annika Blank, et al.
International Journal of Molecular Sciences
|
July 27, 2024
Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (<i>DPYD</i>)
Alisa Ambrodji, Angélique Sadlon, Ursula Amstutz, et al.
Hematological Oncology
|
February 18, 2015
Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma
Martin D Berger, Giacomo Branger, Bernd Klaeser, et al.
Histopathology
|
January 7, 2017
Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer
Gregor Rieger, Viktor H Koelzer, Heather E Dawson, et al.
Haematologica
|
June 20, 2020
Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis
Martin D Berger, Sven Trelle, Annina E Büchi, et al.
Journal of Personalized Medicine
|
August 27, 2021
LAG-3 Expression Predicts Outcome in Stage II Colon Cancer
Gaëlle Rhyner Agocs, Naziheh Assarzadegan, Richard Kirsch, et al.
Human Pathology
|
November 15, 2018
Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer
Heather Dawson, Francesca Galuppini, Peter Träger, et al.
Cancer Treatment Reviews
|
December 6, 2017
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga, Wu Zhang, Madiha Naseem, et al.
Page
of 12